Aminopyrimidinones as interleukin receptor-associated kinase inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9221809
APP PUB NO 20140329799A1
SERIAL NO

14355353

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention relates to aminopyrimidinone compounds of Formula (I) that are inhibitors of Interleukin receptor-associated kinases, in particular IRAK-4, and are useful in the treatment or prevention of inflammatory diseases, including rheumatoid arthritis and inflammatory bowel disease.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MERCK SHARP & DOHME LLC126 EAST LINCOLN AVENUE RAHWAY NJ 07065

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Altman, Michael D Needham, US 65 795
Brumfield, Stephanie Nicole Cranbury, US 1 32
Gibeau, Craig R Natick, US 20 275
Lampe, John William Norfolk, US 2 34
Lavey, Brian J New Providence, US 30 548
Lim, Jongwon Lexington, US 54 531
Matasi, Julius J Monmouth Junction, US 13 206
McElroy, William T Plainfield, US 5 96
Methot, Joey Westwood, US 10 102
Seganish, W Michael Scotch Plains, US 10 97
Tulshian, Deen B Lebanon, US 1 32
Zhu, Liang Belmont, US 120 555

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 29, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00